These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 15180459)

  • 1. Antiviral properties of quinolone-based drugs.
    Richter S; Parolin C; Palumbo M; Palù G
    Curr Drug Targets Infect Disord; 2004 Jun; 4(2):111-6. PubMed ID: 15180459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The history of the development and changes of quinolone antibacterial agents].
    Takahashi H; Hayakawa I; Akimoto T
    Yakushigaku Zasshi; 2003; 38(2):161-79. PubMed ID: 15143768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Broad-spectrum antiviral activity and mechanism of antiviral action of the fluoroquinolone derivative K-12.
    Witvrouw M; Daelemans D; Pannecouque C; Neyts J; Andrei G; Snoeck R; Vandamme AM; Balzarini J; Desmyter J; Baba M; De Clercq E
    Antivir Chem Chemother; 1998 Sep; 9(5):403-11. PubMed ID: 9875393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Current Case of Quinolones: Synthetic Approaches and Antibacterial Activity.
    Naeem A; Badshah SL; Muska M; Ahmad N; Khan K
    Molecules; 2016 Mar; 21(4):268. PubMed ID: 27043501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of Campylobacter jejuni DNA gyrase as the target of quinolones.
    Changkwanyeun R; Usui M; Kongsoi S; Yokoyama K; Kim H; Suthienkul O; Changkaew K; Nakajima C; Tamura Y; Suzuki Y
    J Infect Chemother; 2015 Aug; 21(8):604-9. PubMed ID: 26096494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functionalized N(2-oxyiminoethyl) piperazinyl quinolones as new cytotoxic agents.
    Rajabalian S; Foroumadi A; Shafiee A; Emami S
    J Pharm Pharm Sci; 2007; 10(2):153-8. PubMed ID: 17706174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro Antibacterial Activity of 7-Substituted-6-Fluoroquinolone and 7-Substituted-6,8-Difluoroquinolone Derivatives.
    Leyva-Ramos S; de Loera D; Cardoso-Ortiz J
    Chemotherapy; 2017; 62(3):194-198. PubMed ID: 28334702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, Synthesis and Molecular Docking of 1-Cyclopropyl-6- Fluoro-4-Oxo-7-{4-[2-(4-Substituted-Phenyl)-2-(Substituted)-Ethyl] -1-Piperazinyl}-1,4-Dihydroquinoline-3-Carboxylic Acid as an Antimicrobial Agents.
    Patel MM; Patel LJ
    Curr Drug Discov Technol; 2017; 14(4):255-269. PubMed ID: 28240185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonclassical biological activities of quinolone derivatives.
    Ahmed A; Daneshtalab M
    J Pharm Pharm Sci; 2012; 15(1):52-72. PubMed ID: 22365088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro antibacterial activity of FA103, a new quinolone derivative of C-7 position with 7-perhydrodiazepinone.
    Imamori K; Asaoka T; Matsumoto M; Maebashi K; Matsuda H; Tahara Y
    Jpn J Antibiot; 1995 Dec; 48(12):1891-8. PubMed ID: 8587163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis, molecular docking, and antibacterial evaluation of some novel flouroquinolone derivatives as potent antibacterial agent.
    Patel MM; Patel LJ
    ScientificWorldJournal; 2014; 2014():897187. PubMed ID: 25574496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of mutations in DNA gyrase genes on quinolone resistance in Campylobacter jejuni.
    Changkwanyeun R; Yamaguchi T; Kongsoi S; Changkaew K; Yokoyama K; Kim H; Suthienkul O; Usui M; Tamura Y; Nakajima C; Suzuki Y
    Drug Test Anal; 2016 Oct; 8(10):1071-1076. PubMed ID: 26857529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current Trends and Future Directions of Fluoroquinolones.
    Mohammed HHH; Abuo-Rahma GEAA; Abbas SH; Abdelhafez EMN
    Curr Med Chem; 2019; 26(17):3132-3149. PubMed ID: 29446718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemical structure and pharmacokinetics of novel quinolone agents represented by avarofloxacin, delafloxacin, finafloxacin, zabofloxacin and nemonoxacin.
    Kocsis B; Domokos J; Szabo D
    Ann Clin Microbiol Antimicrob; 2016 May; 15(1):34. PubMed ID: 27215369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual-targeting properties of the 3-aminopyrrolidyl quinolones, DC-159a and sitafloxacin, against DNA gyrase and topoisomerase IV: contribution to reducing in vitro emergence of quinolone-resistant Streptococcus pneumoniae.
    Okumura R; Hirata T; Onodera Y; Hoshino K; Otani T; Yamamoto T
    J Antimicrob Chemother; 2008 Jul; 62(1):98-104. PubMed ID: 18390884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and antibacterial activity of new N-[2-(thiophen-3-yl)ethyl] piperazinyl quinolones.
    Letafat B; Emami S; Mohammadhosseini N; Faramarzi MA; Samadi N; Shafiee A; Foroumadi A
    Chem Pharm Bull (Tokyo); 2007 Jun; 55(6):894-8. PubMed ID: 17541188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of Simian virus 40 large T antigen helicase activity by fluoroquinolones.
    Ali SH; Chandraker A; DeCaprio JA
    Antivir Ther; 2007; 12(1):1-6. PubMed ID: 17503741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-Substituted piperazinyl quinolones as potential cytotoxic agents: structure-activity relationships study.
    Foroumadi A; Emami S; Rajabalian S; Badinloo M; Mohammadhosseini N; Shafiee A
    Biomed Pharmacother; 2009 Mar; 63(3):216-20. PubMed ID: 18328669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The anti-methicillin-resistant Staphylococcus aureus quinolone WCK 771 has potent activity against sequentially selected mutants, has a narrow mutant selection window against quinolone-resistant Staphylococcus aureus, and preferentially targets DNA gyrase.
    Bhagwat SS; Mundkur LA; Gupte SV; Patel MV; Khorakiwala HF
    Antimicrob Agents Chemother; 2006 Nov; 50(11):3568-79. PubMed ID: 16940059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ciprofloxacin and the fluoroquinolones. New concepts on the mechanism of action and resistance.
    Fisher LM; Lawrence JM; Josty IC; Hopewell R; Margerrison EE; Cullen ME
    Am J Med; 1989 Nov; 87(5A):2S-8S. PubMed ID: 2574005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.